* MiMedx Group Inc MDXG.OQ MDXG.O is expected to show a
fall
in quarterly revenue when it reports results on February 28.
* The Marietta Georgia-based company is expected to report
a
7.1% decrease in revenue to $63.689 million from $68.55 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for MiMedx Group Inc is
for a
loss of 3 cents per share. For the same quarter last year, the
company reported a loss of 17 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for MiMedx
Group Inc
is $11, about 55% above its last closing price of $4.95.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 -0.08 -0.08 -0.04 Beat 50
Jun. 30 2021 -0.08 -0.07 -0.03 Beat 59.1
Mar. 31 2021 -0.19 -0.19 -0.09 Beat 52.6
Dec. 31 2020 -0.05 -0.05 -0.17 Missed -240
This summary was machine generated February 26 at 03:01 GMT.
All figures in US dollars unless otherwise stated